Engineered nanomedicine for myeloma and bone microenvironment targeting

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2014-06-30

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1073/pnas.1401337111PMID 24982170PMCID PMC4104924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transepithelial transport of nanoparticles targeted to the neonatal Fc receptor for oral delivery applications

  2013cited by this paper
• Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138− CD34− tumor stem-like cells in multiple myeloma-bearing mice

  2013cited by this paper
• Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery

  2013cited by this paper
• Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

  2013cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Silica Nanoparticles Sensitize Human Multiple Myeloma Cells to Snake (Walterinnesia aegyptia) Venom-Induced Apoptosis and Growth Arrest

  2012cited by this paper
• Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

  2012cited by this paper
• Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.

  2012cited by this paper
• Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Preclinical Development and Clinical Translation of a PSMA-Targeted

  2012cited by this paper
• Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma.

  2012cited by this paper
• Multifunctional Nanoparticles for Drug Delivery Applications

  2012cited by this paper
• Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects

  2011cited by this paper
• Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.

  2010cited by this paper
• Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential.

  2010cited by this paper
• Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma

  2010cited by this paper
• CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

  2009cited by this paper
• Characterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol).

  2009cited by this paper
• Pathogenesis of myeloma bone disease

  2009cited by this paper
• Pathogenesis of myeloma bone disease

  2009cited by this paper
• The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.

  2007cited by this paper
• The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

  2007cited by this paper
• Therapy with Bortezomib plus Dexamethasone Induces Osteoblast Activation in Responsive Patients with Multiple Myeloma

  2007cited by this paper
• 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents.

  2007cited by this paper
• Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

  2006cited by this paper
• Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

  2005cited by this paper
• Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma.

  2005cited by this paper
• Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.

  2003cited by this paper
• Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

  2001cited by this paper

• Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systems.

  2026cites this paper
• Multiple myeloma inhibitory effects of natural compounds: enhancement through nanoparticle carriers

  2025cites this paper
• Cellulose nanofiber reinforced curcumin-infused calcium phosphate silicate cement for various bone-tissue engineering application

  2025cites this paper
• Next‐Generation Therapies for Bone Cancer: Targeted Therapy, Immunotherapy, and Nanomedicine Innovations

  2025cites this paper
• Preliminary assessment of repurposed mebendazole nano-systems for passive targeting and potential treatment of bone metastasis

  2025cites this paper
• Engineered Biomimetic Nanomedicine for Enhanced Bone Marrow Targeted Delivery and Therapy in Multiple Myeloma

  2025cites this paper
• Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy

  2025cites this paper
• Enhanced Bone Targeting of Poly(l-glutamic acid)s through Cationic or Aromatic Substitution.

  2025cites this paper
• Strontium decorated mebendazole alginate nano-platform for bone marrow active targeting for the treatment of bone metastasis

  2025cites this paper
• FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice

  2025influential citation
• Epigenetic Modulation and Bone Metastasis: Evolving Therapeutic Strategies

  2025cites this paper
• Sequential dual-targeting biomimetic nanovesicles for bone marrow–specific delivery of bortezomib in multiple myeloma

  2025cites this paper
• Design and evaluation of a multi-responsive dual-modality bone-targeted drug delivery vehicle for the treatment of osteosarcoma.

  2025cites this paper
• 蛋白酶体抑制剂纳米靶向给药治疗多发性骨髓瘤研究进展

  2025cites this paper
• Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy

  2024cites this paper
• Direct Immobilization of Folic Acid Molecules on Hydroxyapatite Nanoparticles with Substitution and Coordination Phenomena.

  2024cites this paper
• Nanoparticle-encapsulated retinoic acid for the modulation of bone marrow hematopoietic stem cell niche

  2024cites this paper
• Effective encapsulation of therapeutic recombinant enzyme into polymeric nanoparticles as a potential vehicle for lysosomal disease treatment.

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Novel Approaches to Alendronate Delivery Beyond Oral Administration- A Review

  2024cites this paper
• Advancements in drugs restructured with nanomedicines for multiple myeloma treatment

  2024cites this paper
• Recent advances in targeted drug delivery systems for multiple myeloma.

  2024cites this paper
• 2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization

  2024cites this paper
• Bone-Marrow-Targeted Nanocomposite Abrogates C-Myb-Survivin Cross Talk in MLL-AF9-Rearranged Acute Myeloid Leukemia in In Vitro and In Vivo Patient-Derived Xenograft Models.

  2024cites this paper
• Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy.

  2024cites this paper
• Nonviral genetic manipulation system with microenvironmental cascade sensitivity for the treatment of TNBC-associated metastatic bone tumor

  2024cites this paper
• Nanomaterials for bone metastasis.

  2024cites this paper
• Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia.

  2024cites this paper
• Live Cell Imaging by Förster Resonance Energy Transfer Fluorescence to Study Trafficking of PLGA Nanoparticles and the Release of a Loaded Peptide in Dendritic Cells

  2023influential citation
• BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

  2023cites this paper
• Antibody-Mediated Nanodrug of Proteasome Inhibitor Carfilzomib Boosts the Treatment of Multiple Myeloma.

  2023cites this paper
• PLGA-based drug delivery systems in treating bone tumors

  2023cites this paper
• Effect of Nanoparticle Weight on the Cellular Uptake and Drug Delivery Potential of PLGA Nanoparticles

  2023cites this paper
• Targeted Nanoparticles Based on Alendronate Polyethylene Glycol Conjugated Chitosan for The Delivery of Sirna and Curcumin for Bone Metastasized Breast Cancer Applications.

  2023cites this paper
• Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives.

  2023cites this paper
• Multifunctional BPs/MT@PLGA‐ALE Nanospheres for Treatment of Osteoporotic Fracture with Near‐Infrared Irradiation

  2023cites this paper
• Nanoparticle-mediated synergistic drug combination for treating bone metastasis.

  2023cites this paper
• Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma

  2023cites this paper
• Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies

  2023cites this paper
• Precise manipulation of circadian clock using MnO2 nanocapsules to amplify photodynamic therapy for osteosarcoma

  2023cites this paper
• A nanotherapeutic approach for fighting the odds against the malignant disorders

  2023cites this paper
• Targeting Agents Used in Specific Bone-Targeting Drug Delivery Systems: A Review

  2022cites this paper
• Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases

  2022cites this paper
• Research progress of bone-targeted drug delivery system on metastatic bone tumors.

  2022cites this paper
• Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy.

  2022cites this paper
• Drug-loaded PEG-PLGA nanoparticles for cancer treatment

  2022cites this paper
• A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia

  2022cites this paper
• Tough, Flexible, and Bioactive Amphoteric Copolymer-Based Hydrogel for Bone Regeneration without Encapsulation of Seed Cells/Simulating Cues.

  2022cites this paper
• 三种人多发性骨髓瘤细胞系移植小鼠模型的建立和比较

  2022cites this paper
• Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment.

  2022cites this paper
• Bone-targeted biomaterials: strategies and applications

  2022cites this paper
• Targeted Drug Delivery for the Treatment of Blood Cancers

  2022influential citation
• Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate‐decorated albumin nanoclusters in osteosarcoma treatment

  2022cites this paper
• Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy

  2022cites this paper
• Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia

  2022cites this paper
• Pathogenesis and treatment of multiple myeloma

  2022cites this paper
• An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone.

  2021cites this paper
• Bone targeting nanocarrier-assisted delivery of adenosine to combat osteoporotic bone loss.

  2021cites this paper
• Rational nanocarrier design towards clinical translation of cancer nanotherapy

  2021cites this paper
• Toxicity of poly-dispersed single-walled carbon nanotubes on bone marrow derived Hematopoietic Stem and Progenitor Cells

  2021cites this paper
• Daratumumab Immunopolymersome‐Enabled Safe and CD38‐Targeted Chemotherapy and Depletion of Multiple Myeloma

  2021cites this paper
• The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

  2021cites this paper
• DDDT_A_337925 4939..4959

  2021cites this paper
• Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems

  2021cites this paper
• Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases

  2021cites this paper
• New Progress in Improving the Delivery Methods of Bisphosphonates in the Treatment of Bone Tumors

  2021cites this paper
• Remote-controllable bone-targeted delivery of estradiol for the treatment of ovariectomy-induced osteoporosis in rats

  2021cites this paper
• Polymeric nanomedicines targeting hematological malignancies.

  2021cites this paper
• A Bone-Targeting Enoxacin Delivery System to Eradicate Staphylococcus Aureus-Related Implantation Infections and Bone Loss

  2021cites this paper
• Near-Infrared Light and Upconversion Nanoparticle Defined Nitric Oxide-Based Osteoporosis Targeting Therapy.

  2021cites this paper
• Progress of biomaterials for bone tumor therapy

  2021cites this paper
• Luminescent core–shell Ca2MoO5:Eu3+-MCM-41 structure for sustained drug release

  2021cites this paper
• Rationally integrating peptide-induced targeting and multimodal therapies in a dual-shell theranostic platform for orthotopic metastatic spinal tumors.

  2021cites this paper
• Biomaterials for Orthopaedic Diagnostics and Theranostics.

  2021cites this paper
• Degradation-triggered release from biodegradable metallic surfaces.

  2021cites this paper
• Animal Models of Multiple Myeloma Bone Disease

  2021cites this paper
• Optimisation of alendronate conjugation to polyethylene glycol for functionalisation of biopolymers and nanoparticles

  2021cites this paper
• Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer.

  2020cites this paper
• An injectable recombinant human milk fat globule-epidermal growth factor 8-loaded copolymer system for spinal cord injury by reducing inflammation through NF-κB pathway and neuronal cell death.

  2020cites this paper
• Targeted nanomedicines for the treatment of bone disease and regeneration

  2020cites this paper
• Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.

  2020cites this paper
• Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines.

  2020cites this paper
• Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma.

  2020cites this paper
• Tuning Ligand Density to Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.

  2020cites this paper
• Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption

  2020cites this paper
• Utilization of Lipid-Based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib.

  2020cites this paper
• Polymeric Nanoparticles and Their Novel Modifications for Targeted Delivery of Bortezomib

  2020cites this paper
• Bone-targeting polymer vesicles for simultaneous imaging and effective malignant bone tumor treatment.

  2020cites this paper
• CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice.

  2020cites this paper
• PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells.

  2020cites this paper
• Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice

  2020cites this paper
• Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery.

  2020cites this paper
• Bisphosphonates for delivering drugs to bone

  2020cites this paper
• Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine

  2020cites this paper
• Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders

  2020cites this paper
• Enhancing the therapeutic efficacy of bortezomib in cancer therapy using polymeric nanostructures.

  2020cites this paper
• Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges.

  2020cites this paper
• Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

  2020cites this paper
• Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.

  2020cites this paper
• Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.

  2020cites this paper